Kiromic BioPharma Dividend
Dividend criteria checks 0/6
Kiromic BioPharma does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$18.24 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Kiromic Biopharma surges 43% as company to begin lung cancer therapy trial in Q1 next year
Oct 06Dr. Leonardo Mirandola is the new Chief Scientific Officer of Kiromic biopharma
Jul 12Kiromic expands in-house cell therapy manufacturing facility, names new COO
Jun 07Kiromic BioPharma files two IND applications for CAR-T therapy in cancer
Dec 17Kiromic BioPharma reports Q3 results
Nov 30Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if KRBP's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if KRBP's dividend payments have been increasing.
Dividend Yield vs Market
| Kiromic BioPharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (KRBP) | n/a |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.8% |
| Industry Average (Biotechs) | 2.9% |
| Analyst forecast in 3 Years (KRBP) | n/a |
Notable Dividend: Unable to evaluate KRBP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate KRBP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate KRBP's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as KRBP has not reported any payouts.